Over the past 10 years, the U.K.’s National Institute for Health Research (NIHR) has invested in several leading translational research facilities that are individually and collectively delivering substantial impact for patients as well as new opportunities for commercial partnerships and growth. Here, we reflect on the capacity, capability, and year-on-year increase in translational research in the U.K. after a decade of investments (1). We analyze key data demonstrating accelerating performance in several collaborative funding streams and highlight issues to be addressed to ensure sustainable growth in the medium to long term.
展开▼